BioBridgeXAll companies

Soteria Biotherapeutics, Inc.

Biotechnology company · San Francisco, California, United States

Soteria Biotherapeutics, Inc. is a biotechnology company headquartered in San Francisco, California, United States. Its earliest recorded incorporation is in 2018. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $299,600 in total, most recently in 2019. It has reported private securities offerings to the US SEC, most recently $25 million sold in a notice filed in 2021.

www.soteriabiotherapeutics.comProfile compiled from public records. Is this your company? Request a correction or update

Soteria Biotherapeutics at a glance

Typebiotechnology company
HeadquartersSan Francisco, California, United States
Earliest incorporation on record2018
Employees (self-reported, 2019)10
SEC CIK1862212

What does Soteria Biotherapeutics do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $299,600 in total (2019). NIH funding came from the National Cancer Institute.

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $24.9 million sold (2021).

Frequently asked questions about Soteria Biotherapeutics

Where is Soteria Biotherapeutics headquartered?

Soteria Biotherapeutics, Inc. is headquartered in San Francisco, California, United States.

What does Soteria Biotherapeutics do?

Soteria Biotherapeutics, Inc. is a biotechnology company.

When was Soteria Biotherapeutics founded?

The earliest incorporation on record for Soteria Biotherapeutics, Inc. is in 2018, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-25. Data licences